Scientists have developed an innovative penicillin-binding protein inhibitor that could revolutionize treatment for drug-resistant Neisseria gonorrhoeae. This breakthrough uses a boron-based compound to overcome resistance mechanisms that have made gonorrhea increasingly difficult to treat.
After years of relative quiet, tuberculosis research is experiencing a resurgence. Three promising candidates are now in late-stage trials—and they could transform how we fight one of the world's deadliest infectious diseases.
Every week, researchers announce promising new cancer therapies—but most never make it to patients. Discover what separates genuine clinical advances from interesting science, and why the standards for publishing cancer research matter more than ever.
Researchers have identified a promising new biomarker that could revolutionize how we treat the cognitive symptoms of schizophrenia. This discovery opens the door to targeted drug treatments that could help patients struggling with disorganized thinking and executive function challenges.